Transient Ischemic Attack

Clinical Trial Finder

Many patients who experience transient ischemic attacks (TIAs) are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône

Conditions:   Stroke;   Transient Ischemic Attack
Intervention:   Other: Patients with stroke or transient ischemic attack
Sponsor:   Hospices Civils de Lyon
Not yet recruiting - verified May 2017

China Registry of Non-disabling Ischemic Cerebrovascular Events

Conditions:   Transient Ischemic Attack;   Minor Stroke
Intervention:   Other: observational only- no intervention
Sponsors:   The First Affiliated Hospital of Zhengzhou University;   National Health and Family Planning Commission, P.R.China;   Beijing Tiantan Hospital
Not yet recruiting - verified May 2017

Reproducibility Study of Transcranial Doppler

Condition:   Stroke
Intervention:   Diagnostic Test: Transcranial Doppler Ultrasound
Sponsor:   University of Edinburgh
Recruiting - verified May 2017

Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms

Conditions:   Transient Ischemic Attack;   Stroke
Intervention:   Other: Quality Improvement Program
Sponsor:   VA Office of Research and Development
Recruiting - verified May 2017

Detection of Atrial Fibrillation After Cardiac Surgery

Conditions:   Atrial Fibrillation;   Atrial Flutter;   C.Surgical Procedure; Cardiac;   Arrhythmias, Cardiac
Interventions:   Device: Medtronic SEEQ™ mobile cardiac telemetry system;   Other: Usual Care
Sponsor:   St. Michael's Hospital, Toronto
Recruiting - verified May 2017

Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI

Conditions:   Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Active, not recruiting - verified May 2017

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Condition:   Venous Thromboembolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified May 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting - verified May 2017

SLEep APnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke

Conditions:   Stroke;   Transient Ischemic Attack;   Obstructive Sleep Apnea
Interventions:   Device: Portable sleep monitor (ApneaLink Air);   Device: In-laboratory polysomnography
Sponsors:   Sunnybrook Health Sciences Centre;   St. Michael's Hospital, Toronto
Recruiting - verified May 2017

A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF

Condition:   Atrial Fibrillation
Interventions:   Device: single ablation (CryoBalloonAblation (CBA);   Drug: sequential drug adjustment (propafenone, sotalol or flecainide)
Sponsor:   University Hospital, Ghent
Recruiting - verified May 2017

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

Condition:   Stroke
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
Sponsors:   Bayer;   Janssen, LP;   Hamilton Health Sciences Cooperation, Population Health Research Institute
Recruiting - verified May 2017

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2017

Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial

Conditions:   Aortic Valve Disease;   Myocardial Infarction;   Stroke
Interventions:   Drug: Aspirin (80 mg/d) + clopidogrel (75 mg/d);   Drug: Aspirin
Sponsors:   Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec;   Edwards Lifesciences
Completed - verified May 2017

E-Selectin Nasal Instillation to Prevent Secondary Stroke

Conditions:   Ischemic Attack, Transient;   Transient
Intervention:   Drug: Intransal instillation of E-selectin
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting - verified March 23, 2017